KATHLEEN FURLONG: Open Payments
NPI 1205101987 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,613 in 78 payments from 19 companies in 2025. Trend: 2023 $1,470 · 2024 $1,880 · 2025 $1,613
Food & beverage: $1,598Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $869 |
| PFIZER INC. | 5 | $106 |
| ACADIA Pharmaceuticals Inc | 3 | $103 |
| SK Life Science, Inc. | 3 | $76 |
| Axsome Therapeutics, Inc. | 2 | $61 |
| Amgen Inc. | 2 | $48 |
| Boston Scientific Corporation | 2 | $46 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| Biogen, Inc. | 2 | $36 |
| ARGENX US, INC. | 1 | $34 |
Products named: QULIPTA, UBRELVY, BOTOX, NURTEC ODT, NUPLAZID, LEQEMBI, Symbravo, VYALEV.
Industry payments across CA — which companies pay providers there.
